Key result
Higher NfL and p-tau217 levels were independently associated with increased all-cause mortality in hospitalized HF patients.
Why the study?
Phosphorylated Tau-217 (p-tau217) and Neurofilament light (NfL) predict cognitive decline, which is common in heart failure (HF), but their prognostic value for mortality and rehospitalization in HF patients had not been established.
Are higher levels of phosphorylated Tau-217 (p-tau217) and Neurofilament light (NfL) associated with all-cause mortality and heart failure rehospitalization in patients hospitalized for acute heart failure?
Cohort (n=491)
Are higher levels of phosphorylated Tau-217 (p-tau217) and Neurofilament light (NfL) associated with all-cause mortality and heart failure rehospitalization in patients hospitalized for acute heart failure?
In patients hospitalized for acute heart failure, neurological biomarkers p-tau217 and NfL independently predict all-cause mortality but not heart failure rehospitalization, offering prognostic value beyond traditional risk factors.
Answers are grounded in this paper and cite their sources.
May inform mortality prognostication in acute HF beyond traditional factors; hypothesis-generating and requires prospective validation before clinical adoption.
Background Cognitive impairment (CI) is common in heart failure (HF) and associated with increased mortality and morbidity. Phosphorylated Tau-217 (p-tau217) and Neurofilament light (NfL) are biomarkers that have been shown to predict cognitive decline but their prognostic value for mortality and rehospitalization in HF patients has not been established. Aims To investigate whether p-tau217 and NfL are associated with all-cause mortality and rehospitalization in HF patients. Method In 491 patients hospitalized for HF with complete biomarker and covariate; associations between biomarkers and all-cause mortality and rehospitalization for HF were analyzed using Cox proportional hazards models. Models were adjusted for age, sex, BMI, systolic blood pressure and smoking status. Results The median age was 76 years (IQR 67-83) and 31 % were female. 355 deaths occurred during follow-up with a median follow up time of 3.6 years (IQR 1.2 - 6.6). In unadjusted Cox-regression analysis higher levels of p-tau217 and NfL were associated with increased all-cause mortality (HR 1.74 (95% CI = 1.43 – 2.12) and HR 2.27 (95% CI = 1.97 – 2.61), respectively). Associations remained significant after adjustment for both p-tau217 and NfL (HR 1.36 (95% CI 1.09 – 1.69) and HR 1.78 (95% CI = 1.50 – 2.11), respectively). Neither biomarker was significantly associated with HF rehospitalization. Conclusion In patients hospitalized for HF, higher levels of both p-tau217 and NfL were independently associated with all cause-mortality but not with HF rehospitalization. NfL demonstrated a stronger association compared to p-tau217, across all models. These findings suggest that p-tau217 and NfL may provide prognostic information beyond traditional risk factors and biomarkers in HF.
No takes yet. Share an insight, caveat, or question.
Yaghoubi et al. (2026) conducted a cohort in Acute heart failure (n=491). Phosphorylated Tau-217 (p-tau217) and Neurofilament light (NfL) levels vs. Lower biomarker levels (continuous analysis) was evaluated on All-cause mortality (HR 1.78 (adjusted NfL); HR 1.36 (adjusted p-tau217), 95% CI 1.50-2.11). Higher NfL and p-tau217 levels were independently associated with increased all-cause mortality in hospitalized HF patients.
Synapse has enriched 10 related papers. Consider them for comparative context: